Chemistry - LC screening - semi-polar NVOC

Material polarity determines compound migration patterns - semi-polar substances represent the middle ground between water-soluble and lipophilic extractables, requiring intermediate polarity solvents for comprehensive detection. Semi-polar non-volatile compound screening using isopropanol extraction followed by LC-MS provides comprehensive characterization of moderately polar, non-volatile substances occupying the intermediate polarity range between water-soluble and lipophilic extractables. This ISO 10993-12 and 10993-18 compliant analysis captures additives with intermediate polarity including plasticizers and stabilizers, oligomers from polymer processing, and degradation products formed through oxidation or hydrolysis reactions. The isopropanol extraction effectively solubilizes semi-polar compounds while maintaining compatibility with LC-MS analysis through appropriate dilution or solvent exchange, enabling direct injection without extensive sample preparation. Critical for devices containing polyurethanes where semi-polar additives enable processing and provide material properties, modified polymers with grafted functional groups creating intermediate polarity, and materials with complex additive packages requiring comprehensive characterization across polarity ranges. The LC-MS methodology accommodates compounds too polar for GC analysis yet not sufficiently ionic for standard reverse-phase LC, using gradient elution separating compounds across wide polarity range. Manufacturing validation confirms that processing removes semi-polar solvents used in fabrication, sterilization doesn't generate semi-polar degradation products, and aging doesn't produce oxidation products requiring safety assessment. For implantable devices, semi-polar extractables assessment characterizes chronic exposure to moderately polar compounds that accumulate at implant-tissue interfaces, while cardiovascular devices need screening ensuring blood contact doesn't extract harmful semi-polar additives.

No.
10062341
Method
IPA extraction, LC-MS non-volatile screening
Analyses category
Sample type
Finished device, Bulk material
Sample requirement (type)
Sterile or non sterile
Sample quantities
15 cm2, 0,5 gram
Lead Time Standard (Days)
30
Lead Time Express (Days)
unavailable
Lead Time Super Express (Days)
15
Test facility
Partner Lab
GLP
No
Add this test to cart to request an offer.

Do you need some help?

Other similar tests

ISO 10993-12, ISO 10993-18, USP 1663, USP 1664
Chemistry - LC Screening - non-polar NVOC

Lipophilic non-volatile compounds represent the most challenging extractables - high molecular weight hydrophobic substances resist both aqueous extraction and GC analysis, requiring aggressive organic extraction and LC-MS for detection. Non-polar extraction using hexane followed by LC-MS analysis targets lipophilic, non-volatile compounds that complement GC-MS screening by capturing high molecular weight hydrophobic substances resistant to volatilization. Following ISO 10993-12 and 10993-18 requirements, this approach captures non-volatile plasticizers providing flexibility without vapor pressure, complex lipophilic additives including stabilizer packages and UV absorbers, and high molecular weight hydrophobic components that standard GC methods cannot analyze. Essential for devices with rubber components containing non-volatile additives including polymeric plasticizers and high molecular weight antioxidants, silicone devices with high molecular weight components like PDMS oligomers, and materials where comprehensive characterization requires both volatile and non-volatile analysis spanning full molecular weight range. The hexane extraction aggressively solubilizes lipophilic substances providing worst-case assessment, while LC-MS enables analysis of high molecular weight compounds through softer ionization preventing fragmentation. For implantable devices, non-volatile lipophilic extractables accumulate in fatty tissues surrounding implants creating chronic exposure scenarios requiring characterization, while blood-contacting devices need assessment ensuring lipophilic compounds don't partition into lipoproteins causing systemic distribution. The analysis proves particularly valuable when investigating cytotoxicity potentially caused by high molecular weight extractables that volatile screening misses, validating new polymers with unknown additive compositions, or qualifying alternative suppliers whose formulations differ from established materials.